|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.66 USD | +0.14% |
|
-1.99% | -28.36% |
| 07-16 | RxSight Names Aziz Mottiwala as CEO | MT |
| 07-14 | Tarsus Pharmaceuticals, Inc. Announces Management Changes, Effective July 13, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| TARSUS PHARMACEUTICALS, INC. | Biopharmaceuticals | +0.14% | -1.99% | -28.36% | +41.35% | +126.40% | 2.52B |  | |  |
- Stock Market
- Stocks
- TARS Stock
- Charts Tarsus Pharmaceuticals, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
